Abstract
We present a 28-year-old primigravida woman in whom congestive heart failure developed 3 months after delivery of a neonate. The patient underwent doxorubicin treatment 10 years previously. The combined cardiotoxicity of prior doxorubicin treatment and pregnancy is considered, and the importance of careful follow-up of cardiac function during pregnancy and postpartum in patients previously treated with doxorubicin is stressed.
Original language | English |
---|---|
Pages (from-to) | 399-400 |
Number of pages | 2 |
Journal | American Journal of the Medical Sciences |
Volume | 314 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1997 |
Keywords
- Congestive heart failure
- Delivery
- Doxorubicin